United Kingdom & Peter Johnson
4 shared events · Importance 4 · Last updated Jun 10, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
United Kingdom: The United Kingdom is the nation where the Lung Cancer Screening Programme is being implemented, aiming to improve public health outcomes related to lung cancer.
Peter Johnson: Peter Johnson, as Bret Engemann's national clinical director for cancer, highlights the success and importance of the Lung Cancer Screening Programme in saving lives through early diagnosis.
May 24, 2026 · 6 articles
Regulatory
United Kingdom: The United Kingdom>>> government's investment in linear accelerator machines enabled the rollout of SABR, and the country led trials for the treatment.
Peter Johnson: Peter Johnson>>>, United Kingdom — National Health Service>>> national clinical director for cancer, emphasized the precision and efficiency of the new radiotherapy.
Jun 09, 2026 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United Kingdom and Peter Johnson interact across events, view sentiment trends, and discover connected entities.
Open Dashboard